At McDermott Will & Emery’s 2018 Physician Practice Management and ASC Symposium, some of the leading minds in the PPM and ASC fields gathered to discuss key issues and their thoughts on the future growth and direction of the
Health & Life Sciences News
Exploring Critical Business and Legal Issues across the Health Care and Life Sciences Industries
Health & Life Sciences News, published by McDermott Will & Emery, focuses on legal and regulatory developments affecting the healthcare and life sciences sectors. The blog covers topics such as healthcare mergers and acquisitions, compliance programs, antitrust considerations, provider collaborations, and the impact of public health emergencies like COVID-19 on healthcare operations and life sciences companies. It also addresses FDA regulatory issues, clinical trial innovations, supply chain challenges, and government assistance programs relevant to healthcare and life sciences businesses. The content includes analysis of transactional, compliance, and policy matters shaping the industry landscape.
Latest from Health & Life Sciences News - Page 7
A PPM Preview: Q&A with Leaders on What’s Driving the Industry
Physician practice management (PPM) and ambulatory surgery center (ASC) companies continue to attract tremendous attention of private equity investors and continue to play a key and growing role in the healthcare services sector.
In advance of our 2018 Physician Practice…
Riding the PPM Wave of the 90s: Learning from the Crash to Prepare for the Future
The ‘90s was a wild ride for the physician practice management (PPM) industry. I know this from personal experience. I rode the PPM consolidation wave of the ‘90s up to the top – and I saw it crash based on…
5 Key Topics Explored at McDermott’s 2018 PPM & ASC Symposium
There are many critical issues facing the physician practice management (PPM) and ambulatory surgery center (ASC) industries today, including the effects of sky-high valuations, concerns about sustainability, and the importance of delivering on value. This current environment demands new approaches…
Q&A: Shifting Trends in Specialty Pharmacy to Continue in 2018
Specialty pharmacy is not going away any time soon – by 2020, it’s expected that the pharmacy industry’s revenue will exceed $483 billion, with almost all growth as a result of specialty drugs (high-cost medications used to treat…
Where Health and Investment Collide: Health Care Private Equity Trends to Watch in 2018
Since the announcement in late January that Amazon, Berkshire Hathaway and JPMorgan were teaming up to “disrupt health care,” the intersection of health and business has been top of mind for many. As we wait with bated breath to see…